Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas with poor outcomes on current therapy. We investigated whether response …

The prognosis of peripheral T-cell lymphoma (PTCL) is heterogenous. Baseline or interim
imaging characteristics may inform risk-adapted treatment paradigms. We identified 112 …

Abstract The prospective randomized Positron Emission Tomography (PET)‐Guided
Therapy of Aggressive Non‐Hodgkin Lymphomas (PETAL) trial was designed to test the …

Background Most peripheral T-cell lymphoma (PTCL) patients have a poor outcome and the
identification of prognostic factors at diagnosis is needed. Patients and methods The …

The purpose of this study was to compare in a large series of peripheral T cell lymphoma, as
a model of diffuse disease, the prognostic value of baseline total metabolic tumor volume …

Purpose The aim of this study was to explore the prognostic value of total metabolic tumor
volume (TMTV) at baseline 18 F-FDG PET/CT in patients diagnosed with peripheral T-cell …

Abstract Background. 18F-FDG-PET/CT has been widely used in the staging of malignant
lymphomas, and accepted as a tool for response assessment. Among PET parameters, the …

Purpose To determine whether metabolic tumor parameters and radiomic features extracted
from 18 F-FDG PET/CT (PET) can predict response to therapy and outcome in patients with …

Purpose. In the present study, we aimed to investigate whether the metabolic parameters on
baseline 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (18 …

Backgrounds The role of interim PET/CT in peripheral T-cell lymphoma (PTCL) is less
identified compared to other subtype of lymphoma. This study prospectively investigated the …